Abstract

Huntington’s disease (HD) is characterized by protein inclusions and loss of striatal neurons which result from expanded CAG repeats in the poly-glutamine (polyQ) region of the huntingtin (HTT) gene. Both polyQ expansion and loss of HTT have been shown to cause axonal transport defects. While studies show that HTT is important for vesicular transport within axons, the cargo that HTT transports to/from synapses remain elusive. Here, we show that HTT is present with a class of Rab4-containing vesicles within axons in vivo. Reduction of HTT perturbs the bi-directional motility of Rab4, causing axonal and synaptic accumulations. In-vivo dual-color imaging reveal that HTT and Rab4 move together on a unique putative vesicle that may also contain synaptotagmin, synaptobrevin, and Rab11. The moving HTT-Rab4 vesicle uses kinesin-1 and dynein motors for its bi-directional movement within axons, as well as the accessory protein HIP1 (HTT-interacting protein 1). Pathogenic HTT disrupts the motility of HTT-Rab4 and results in larval locomotion defects, aberrant synaptic morphology, and decreased lifespan, which are rescued by excess Rab4. Consistent with these observations, Rab4 motility is perturbed in iNeurons derived from human Huntington’s Disease (HD) patients, likely due to disrupted associations between the polyQ-HTT-Rab4 vesicle complex, accessory proteins, and molecular motors. Together, our observations suggest the existence of a putative moving HTT-Rab4 vesicle, and that the axonal motility of this vesicle is disrupted in HD causing synaptic and behavioral dysfunction. These data highlight Rab4 as a potential novel therapeutic target that could be explored for early intervention prior to neuronal loss and behavioral defects observed in HD.

Highlights

  • Huntington’s disease (HD) is a deadly, dominantlyinherited neurodegenerative disorder that is caused by expansion of CAG repeats in the poly-glutamine tract (> 35 repeats) in the huntingtin (HTT) gene

  • Despite growing evidence of a role for HTT in axonal transport, the specific vesicle complexes that HTT is present on, and the cargoes that HTTcontaining vesicles carry during long distance axonal motility in vivo remain elusive

  • Using a combination of in vitro and in vivo analysis, and a variety of model systems including Drosophila, mice, and iNeurons derived from induced pluripotent stem cells obtained from HD patients, we identified the role of HTT in the axonal motility of Rab4-containing vesicles

Read more

Summary

Introduction

Huntington’s disease (HD) is a deadly, dominantlyinherited neurodegenerative disorder that is caused by expansion of CAG repeats in the poly-glutamine (polyQ) tract (> 35 repeats) in the huntingtin (HTT) gene. The earliest known dysfunction seen in HD involves changes to synaptic proteins and deficits in synaptic plasticity [52]. These defects could arise due to disruption of long-distance transport within axons. HTT moves bidirectionally within axons [7] and reduction of Drosophila HTT (htt) causes axonal accumulations [24, 36, 75, 76], similar to what has been observed with loss of motor protein function [23]. We previously identified functional interactions between HTT and molecular motors kinesin-1 and dynein [78]. Despite growing evidence of a role for HTT in axonal transport, the specific vesicle complexes that HTT is present on, and the cargoes that HTTcontaining vesicles carry during long distance axonal motility in vivo remain elusive

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call